It continues the pattern of aggressively moving into US oncology field by Japanese companies: 1. 2007 Eisai - MGI 2. 2008 Takeda - Millennium 3. 2010 Astellas - OSI, 2009 big partnership with Medivation, 2011 with AVEO 4. 2011 Daiichi Sankyo - Plexxikon